IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1
54
about 4.7 years
18+
1 site in TX
What this study is about
This trial is testing a treatment called IACS-6274, possibly with bevacizumab and paclitaxel, to see if it's safe and tolerable in people with advanced solid tumors. The goal is to find the highest dose that can be given safely.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Bevacizumab
- 2.Take Capivasertib
- 3.Take Glutaminase-1 Inhibitor IACS-6274
- +1 more
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
bevacizumab, capivasertib, paclitaxel (Taxane chemotherapy; stabilizes microtubules)
infusion, oral (Oral Tablet), injection, intravenous
Primary: Incidence of adverse events (AEs)
Oncology